Medtronic Deferred Long Term Liab from 2010 to 2025
| MDT Stock | USD 87.99 0.00 0.00% |
Deferred Long Term Liabilities | First Reported 2014-04-30 | Previous Quarter 747 M | Current Value 708 M | Quarterly Volatility 1.4 B |
Check Medtronic PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medtronic PLC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.2 B, Interest Expense of 868.2 M or Total Revenue of 39.1 B, as well as many indicators such as Price To Sales Ratio of 5.29, Dividend Yield of 0.011 or PTB Ratio of 5.46. Medtronic financial statements analysis is a perfect complement when working with Medtronic PLC Valuation or Volatility modules.
Medtronic | Deferred Long Term Liab |
Latest Medtronic PLC's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Medtronic PLC over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Medtronic PLC's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medtronic PLC's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Medtronic Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 1,337,283,750 | |
| Geometric Mean | 949,258,927 | |
| Coefficient Of Variation | 97.49 | |
| Mean Deviation | 935,108,125 | |
| Median | 884,000,000 | |
| Standard Deviation | 1,303,747,959 | |
| Sample Variance | 1699758.7T | |
| Range | 4.3B | |
| R-Value | (0.18) | |
| Mean Square Error | 1764740.6T | |
| R-Squared | 0.03 | |
| Significance | 0.51 | |
| Slope | (48,203,382) | |
| Total Sum of Squares | 25496381.1T |
Medtronic Deferred Long Term Liab History
About Medtronic PLC Financial Statements
Medtronic PLC shareholders use historical fundamental indicators, such as Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Medtronic PLC investors may analyze each financial statement separately, they are all interrelated. The changes in Medtronic PLC's assets and liabilities, for example, are also reflected in the revenues and expenses on on Medtronic PLC's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 637.2 M | 605.3 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.